25
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Treatment of Induced Murine SLE with a Peptide Based on the CDR3 of an Anti-DNA Antibody Reverses the Pattern of Pathogenic Cytokines

, &
Pages 211-219 | Published online: 07 Jul 2009

  • Shoenfeld, Y. and Mozes, E. (1990) "Pathogenic idiotypes of autoantibodies in autoimmunity", FASEB J. 4, 2646 - 2651
  • Kotzin, B.L. and O'Dell, J.R. (1995) "Systemic lupus erythematosus", In: Frank, M.M., Austen, K.F., Claman, H.N. and Unanue, E.R., eds, Samter's Immunologic Diseases (Little, Brown and Co., Boston), pp 667 - 697
  • Mendlovic, S., Brocke, S., Shoenfeld, Y., Ben Basat, M., Meshorer, A., Bakimer, R. and Mozes, E. (1988) "Induction of a systemic lupus erythematosus like disease in mice by a common human anti-DNA idiotype", Proc. Natl Acad. Sci. USA 85, 2260 - 2264
  • Waisman, A., Mendelovic, S., Ruiz, J.P., Zinger, H., Meshorer, A. and Mozes, E. (1993) "The role of the 16/6 idiotype network in the induction and manifestation of systemic lupus erythematosus", Int. Immunol. 5, 1293 - 1300
  • Waisman, A. and Mozes, E. (1993) "Variable regions of autoantibodies isolated from mice with experimental systemic lupus erythematosus", Eur. J. Immunol. 23, 1566 - 1573
  • Waisman, A., Ruiz, J.P., Israeli, E., Eilat, E., Konen-Waisman, S., Zinger, H., Dayan, M. and Mozes, E. (1997) "Modulation of murine systemic lupus erythematosus with peptides based on complementarity determining regions of a pathogenic anti-DNA monoclonal antibody", Proc. Natl Acad. Sci. USA 94, 4620 - 4625
  • Brosh, N., Zinger, H., Fridkin, M. and Mozes, E. (2000) "A peptide based on the sequence of the CDR3 of a murine anti-DNA mAb is a better modulator of experimental SLE than its single amino acid substituted analogs", Cell Immunol. 205, 52 - 61
  • Brosh, N., Eilat, E., Zinger, H. and Mozes, E. (2000) "Characterization and role in experimental SLE of T cell lines specific to peptides based on CDR1 and CDR3 of a pathogenic anti-DNA monoclonal antibody", Immunology 99, 257 - 265
  • Brosh, N., Dayan, M., Fridkin, M. and Mozes, E. (2000) "A peptide based on the CDR3 of an anti-DNA antibody of experimental SLE origin is a dominant T cell epitope also in (NZBXNZW)F1 lupus-prone mice", Immunol. Lett. 72, 61 - 68
  • Handwerger, B.S., Rus, V., da Silva, L. and Via, C.S. (1994) "The role of cytokines in the immunopathogenesis of lupus", Springer Semin. Immunopathol. 16, 153 - 180
  • Horwitz, D.A. and Jacob, C.O. (1994) "The cytokine network in the pathogenesis of systemic lupus erythematosus and possible therapeutic implications", Springer Semin. Immunopathol. 16, 181 - 200
  • Theofilopoulos, A.N. and Lawson, B.R. (1999) "Tumor necrosis factor and other cytokines in murine lupus", Ann. Rheum. Dis. 58 (1), 149 - 155
  • Segal, R., Bermas, B.L., Dayan, M., Kalush, F., Shearer, G.M. and Mozes, E. (1997) "Kinetics of cytokine production in experimental systemic lupus erythematosus: involvement of T helper cell 1/T helper cell 2-type cytokines in disease", J. Immunol. 158, 3009 - 3016
  • Holdsworth, S.R., Kitching, A.R. and Tipping, P.G. (1999) "Th1 and Th2 T helper cell subsets affect patterns of injury and outcome in glomerulonephritis", Kidney Int. 55, 1198 - 1216
  • Merrifield, R. (1986) "Solid phase synthesis", Science 232, 341 - 347
  • Waisman, A., Shoenfeld, Y., Blank, M., Ruiz, P.J. and Mozes, E. (1995) "The pathogenic human monoclonal anti-DNA that induces experimental systemic lupus erythematosus in mice is encoded by a VH4 gene segment", Int. Immunol. 7, 689 - 696
  • Mao, C., Osman, G.E., Adams, S. and Datta, S.K. (1994) "T cell receptor alpha-chain § repertoire of pathogenic autoantibody-inducing T cells in lupus mice", J. Immunol. 152, 1462 - 1470
  • Beverly, B., Kang, S.M., Lenardo, J. and Schwartz, R.H. (1992) "Reversal of in vitro T cell clonal anergy by IL-2 stimulation", Int. Immunol. 4, 661 - 671
  • Gibert, K.M. and Weigle, W.O. (1993) "Th1 cell anergy and blockade in G1a phase of the cell cycle", J. Immunol. 151, 1245 - 1254
  • Powell, J.D., Lerner, C.G. and Schartz, R.H. (1999) "Inhibition of cell cycle progression by Rapamycin induces T cell clonal anergy even in the presence of costimulation", J. Immunol. 162, 2775 - 2784
  • Dean, G.S., Tyrrell-Price, J., Crawley, E. and Isenberg, D.A. (2000) "Cytokines and systemic lupus erythematosus", Ann. Rheum. Dis. 59, 243 - 251
  • Horwitz, D.A., Wang, H. and Gray, J.D. (1994) "Cytokine gene profile in circulating blood mononuclear cells for patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA", Lupus 3, 423 - 428
  • Viallard, J.F., Pellegrin, J.L., Ranchin, V., Schaaeverbeke, T., Dehais, J., Longy-Boursier, M., et al., (1999) "Th1 (IL-2, IFN-gamma) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE)", Clin. Exp. Immunol. 115, 189 - 195
  • Amital, H., Levi, Y., Blank, M., Barak, V., Langevitz, P., Afek, A., et al., (1998) "Immunomodulation of murine experimental SLE-like disease by interferon-gamma", Lupus 7, 445 - 454
  • Haas, C., Ryffel, B. and Le Hir, M. (1997) "IFN-gamma is essential for the development of autoimmune glomerulonephritis in MRL/Ipr mice", J. Immunol. 158, 5484 - 5491
  • Peng, S.L.M.J. and Craft, J. (1997) "Roles of interferon-gamma and interleukin-4 in murine lupus", J. Clin. Investig. 99, 1936 - 1946
  • Jacob, C.O., van der Meide, P.H. and McDevitt, H.O. (1987) "In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon", J. Exp. Med. 166, 798 - 803
  • Ozmen, L., Roman, D., Fountoulakis, M., Schmid, G., Ryffel, B. and Garotta, G. (1995) "Experimental therapy of systemic lupus erythematosus: the treatment of NZB/W mice with mouse soluble interferon-gamma receptor inhibits the onset of glomerulonephritis", Eur. J. Immunol. 25, 6 - 12
  • Davas, E.M., Tsirogianni, A., Kappou, I., Karamitsos, D., Economidou, I. and Dantis, P.C. (1999) "Serum IL-6, TNFalpha, p55 srTNFalpha, p75sr TNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus", Clin. Rheumatol. 18, 17 - 22
  • Segal, R., Dayan, M., Zinger, H. and Mozes, E. (1995) "Methotrexate treatment in murine experimental systemic lupus erythematosus (SLE); clinical benefits associated with cytokine manipulation", Clin. Exp. Immunol. 101, 66 - 72
  • Dayan, M., Zinger, H., Kalush, F., Mor, G., Amir-Zaltzman, Y., Kohen, F., et al., (1997) "The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimentalsystemic lupus erythematosus are associated with cytokine modulations", Immunology 90, 101 - 108
  • Segal, R., Dayan, M., Zinger, H. and Mozes, E. (2001) "Suppression of experimental systemic lupus erythematosus (SLE) in mice via TNF inhibition by an anti-TNFα monoclonal antibody and by pentoxiphyline", Lupus 10, 23 - 31
  • Yaswen, L., Kulkarni, A.B., Fredrickson, T., Mittleman, B., Schiffman, R., Payne, S., et al., (1996) "Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse", Blood 87, 1439 - 1445
  • Ohtsuka, K., Gray, J.D., Stimmler, M.M., Toro, B. and Horwitz, D.A. (1998) "Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus", J. Immunol. 160, 2539 - 2545
  • Kitamura, M., Suto, T., Yokoo, T., Shimizu, F. and Fine, L.G. (1996) "Transforming growth factor-beta is the predominant paracrine inhibitor of macrophage cytokine synthesis produced by glomerular mesengial cells", J. Immunol. 156, 2964 - 2971
  • Eilat, E., Zinger, H., Nyska, A. and Mozes, E. (2000) "Prevention of systemic lupus erythematosus-like disease in (NZBxNZW)F1 mice by treating with CDR1- and CDR3-based peptides of a pathogenic autoantibody", J. Clin. Immunol. 20, 268 - 278
  • Wloch, M.K., Alexander, A.L., Pippen, A.M.N., Pisetsky, D.S. and Gilkson, G.S. (1997) "Molecular properties of anti-DNA induced in preautoimmune NZB/W mice by immunization with bacterial DNA", J. Immunol. 158, 4500 - 4506
  • Tillman, D., Nainn-Tsyr, J., Hill, R. and Marion, T. (1992) "Both IgM and IgG anti-DNA antibodies are the products of clonally selective B cell stimulation in (NZBxNZW)F1 mice", J. Exp. Med. 176, 761 - 779
  • Jouanne, C., Avrameas, S. and Payelle-Brogard, B. (1999) "A peptide derived from a polyreactive monoclonal anti-DNA natural antibody can modulate lupus development in (NZBXNZW)F1 mice", Immunology 96, 333 - 339
  • Kaliyaperumal, A., Michaels, M.A. and Datta, S.K. (1999) "Antigen-specific therapy of murine lupus nephritis using nucleosomal peptides: tolerance spreading impairs pathogenic function of autoimmune T and B cells", J. Immunol. 162, 5775 - 5783
  • Gaynor, B., Putterman, C., Valadon, P., Spatz, L., Scharff, M.D. and Diamond, B. (1997) "Peptide inhibition of glomerular deposition of an anti-DNA antibody", Proc. Natl Acad. Sci. USA 94, 1955 - 1960
  • Singh, R.R., Ebling, F.M., Sercarz, E.E. and Hahn, B.H. (1995) "Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus", J. Clin. Investig. 96, 2990 - 2996

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.